David Weber
Overview
Explore the profile of David Weber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1325
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thankan R, Thomas E, Weldemariam M, Purushottamachar P, Huang W, Kane M, et al.
Mol Oncol
. 2025 Feb;
PMID: 40007440
Cholesterol (CHOL) homeostasis is significantly modulated in prostate cancer (PCa) suggesting an active role in PCa development and progression. Several studies indicate a strong correlation between elevated CHOL levels and...
2.
Levine M, Li D, Roizen J, Weber D
J Bone Miner Res
. 2024 Dec;
40(3):445-446.
PMID: 39714216
No abstract available.
3.
Bresadola L, Weber D, Ritzel C, Lower M, Bukur V, Akilli-Ozturk O, et al.
BJC Rep
. 2024 Nov;
2(1):62.
PMID: 39516649
Background: Head and neck squamous cell carcinomas (HNSCCs) are heterogeneous in terms of origin and aetiology. In addition, there is uncertainty about the genetic evolution from initial diagnosis to recurrence...
4.
Lang F, Sorn P, Suchan M, Henrich A, Albrecht C, Kohl N, et al.
Bioinform Adv
. 2024 Jun;
4(1):vbae080.
PMID: 38863673
Motivation: Neoantigens are promising targets for cancer immunotherapies and might arise from alternative splicing. However, detecting tumor-specific splicing is challenging because many non-canonical splice junctions identified in tumors also appear...
5.
Fink P, Wheeler 3rd A, Smith W, Brant-Zawadzki G, Lieberman J, McIntosh S, et al.
Wilderness Environ Med
. 2024 Apr;
35(2):198-218.
PMID: 38651342
The Wilderness Medical Society (WMS) convened an expert panel to develop evidence-based guidelines for the management of pain in austere environments. Recommendations are graded based on the quality of supporting...
6.
Van Tilburg C, Paal P, Strapazzon G, Grissom C, Haegeli P, Holzl N, et al.
Wilderness Environ Med
. 2024 Apr;
35(2):252-253.
PMID: 38629489
No abstract available.
7.
Lang F, Sorn P, Schrors B, Weber D, Kramer S, Sahin U, et al.
iScience
. 2023 Nov;
26(11):108014.
PMID: 37965155
Previous studies showed that the neoantigen candidate load is an imperfect predictor of immune checkpoint blockade (ICB) efficacy. Further studies provided evidence that the response to ICB is also affected...
8.
Van Tilburg C, Paal P, Strapazzon G, Grissom C, Haegeli P, Holzl N, et al.
Wilderness Environ Med
. 2023 Nov;
35(1_suppl):20S-44S.
PMID: 37945433
To provide guidance to the general public, clinicians, and avalanche professionals about best practices, the Wilderness Medical Society convened an expert panel to revise the evidence-based guidelines for the prevention,...
9.
Inoue J, Weber D, Fernandes J, Adegnika A, Agnandji S, Lell B, et al.
Infection
. 2023 Jul;
51(6):1759-1765.
PMID: 37501013
Purpose: Fever is a common cause for hospitalization among the pediatric population. The spectrum of causative agents is diverse. Human herpesvirus 6 (HHV-6) is a ubiquitous virus that often causes...
10.
Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens
Weber D, Ibn-Salem J, Sorn P, Suchan M, Holtstrater C, Lahrmann U, et al.
Nat Biotechnol
. 2022 Apr;
40(8):1276-1284.
PMID: 35379963
Cancer-associated gene fusions are a potential source for highly immunogenic neoantigens, but the lack of computational tools for accurate, sensitive identification of personal gene fusions has limited their targeting in...